236 related articles for article (PubMed ID: 16165720)
21. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension.
Cottone S; Mulè G; Nardi E; Vadalà A; Lorito MC; Guarneri M; Arsena R; Palermo A; Cerasola G
J Hypertens; 2007 Feb; 25(2):423-8. PubMed ID: 17211250
[TBL] [Abstract][Full Text] [Related]
23. [Possibility of early diagnosis of hepatic fibrosis in chronic alcoholics determining the N-terminal peptide of type-III procollagen].
Ricciardi R; Restuccia G
Quad Sclavo Diagn; 1988; 24(1-4):171-8. PubMed ID: 3077474
[TBL] [Abstract][Full Text] [Related]
24. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
Sciarretta S; Ferrucci A; Ciavarella GM; De Paolis P; Venturelli V; Tocci G; De Biase L; Rubattu S; Volpe M
Am J Hypertens; 2007 Jul; 20(7):784-91. PubMed ID: 17586414
[TBL] [Abstract][Full Text] [Related]
25. A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis.
Başkol M; Başkol G; Deniz K; Ozbakir O; Yücesoy M
Turk J Gastroenterol; 2005 Sep; 16(3):119-23. PubMed ID: 16245219
[TBL] [Abstract][Full Text] [Related]
26. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM
Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915
[TBL] [Abstract][Full Text] [Related]
27. Enhanced lipid peroxidation in hepatic cirrhosis.
Pratico D; Iuliano L; Basili S; Ferro D; Camastra C; Cordova C; FitzGerald GA; Violi F
J Investig Med; 1998 Feb; 46(2):51-7. PubMed ID: 9549227
[TBL] [Abstract][Full Text] [Related]
28. Relationship between oxidative stress and essential hypertension.
Rodrigo R; Prat H; Passalacqua W; Araya J; Guichard C; Bächler JP
Hypertens Res; 2007 Dec; 30(12):1159-67. PubMed ID: 18344620
[TBL] [Abstract][Full Text] [Related]
29. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
30. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
[TBL] [Abstract][Full Text] [Related]
31. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure.
Kotlyar E; Vita JA; Winter MR; Awtry EH; Siwik DA; Keaney JF; Sawyer DB; Cupples LA; Colucci WS; Sam F
J Card Fail; 2006 Mar; 12(2):122-7. PubMed ID: 16520260
[TBL] [Abstract][Full Text] [Related]
32. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
33. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
Karamouzis I; Sarafidis PA; Karamouzis M; Iliadis S; Haidich AB; Sioulis A; Triantos A; Vavatsi-Christaki N; Grekas DM
Am J Nephrol; 2008; 28(3):397-404. PubMed ID: 18063858
[TBL] [Abstract][Full Text] [Related]
34. Ursodeoxycholic acid in primary biliary cirrhosis improves glutathione status but fails to reduce lipid peroxidation.
Pemberton PW; Aboutwerat A; Smith A; Warnes TW
Redox Rep; 2006; 11(3):117-23. PubMed ID: 16805966
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory response to a high-fat, low-carbohydrate weight loss diet: effect of antioxidants.
Peairs AT; Rankin JW
Obesity (Silver Spring); 2008 Jul; 16(7):1573-8. PubMed ID: 18451774
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis.
Naveau S; Abella A; Raynard B; Balian A; Giraud V; Montembault S; Mathurin P; Keros LG; Portier A; Capron F; Emilie D; Galanaud P; Chaput JC
Am J Gastroenterol; 2001 Dec; 96(12):3361-7. PubMed ID: 11774950
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
Das KS; Balakrishnan V; Mukherjee S; Vasudevan DM
Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067
[TBL] [Abstract][Full Text] [Related]
38. Endothelial function, CRP and oxidative stress in chronic kidney disease.
Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
[TBL] [Abstract][Full Text] [Related]
39. [New suggestions for the management of alcoholic liver diseases].
Jmelnitzky AC
Acta Gastroenterol Latinoam; 1995; 25(2):73-84. PubMed ID: 8525763
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
Harzallah O; Kerkeni A; Baati T; Mahjoub S
Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
